Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 16, 2025 07:00 ET | Source: Endure Biotherapeutics, Inc.

National PKU Alliance Grant Advances Engineered Native Bacteria Candidate for Phenylketonuria (PKU)

San Diego, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Endure Biotherapeutics, Inc. (Endure Bio®), a pioneer in engineered engraftable microbial therapeutics, today announced that its founding discovery...
October 14, 2025 10:30 ET | Source: SNS Insider pvt ltd

Global Human Microbiome Market to Reach USD 5.45 Billion by 2033, Driven by Therapeutic Advances, Genomics Innovations, and Rising Consumer Demand for Gut Health Solutions – SNS Insider

Austin, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Human Microbiome Market Size & Growth Analysis According to SNS Insider, the global Human Microbiome Market was valued at USD 1.39 billion in 2025E and...
October 08, 2025 10:29 ET | Source: EnteroTrack

Medicare Now Reimbursing for EnteroTrack’s Esophageal String Test®, Expanding Access to Patients with Eosinophilic Esophagitis

Medicare now reimburses EnteroTrack’s Esophageal String Test®, expanding patient access to minimally invasive EoE monitoring nationwide.
September 30, 2025 04:12 ET | Source: Research and Markets

Human Microbiome Market Industry Research 2025-2035: 70+ Developers, 230+ Pipeline Drugs and 75+ Screening Tests Drive Global Growth

Dublin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The "Human Microbiome Market Industry Trends and Global Forecasts to 2035, by Type of Product, Type of Molecule, Target Indication, Therapeutic Area, Route...
September 29, 2025 15:30 ET | Source: Persephone Biosciences, Inc.

Persephone Biosciences Co-Sponsors Event With Clean Label Project At Annual American Academy Of Pediatrics Conference

Persephone Biosciences Co-Sponsors Event With Clean Label Project At Annual American Academy Of Pediatrics Conference
September 09, 2025 06:00 ET | Source: Persephone Biosciences, Inc.

Persephone Biosciences Unveils First-Of-Its-Kind Synbiotic Designed To Restore Critical Gut Microbes In Babies

Persephone Biosciences Unveils First-Of-Its-Kind Synbiotic Designed To Restore Critical Gut Microbes In Babies
September 08, 2025 15:07 ET | Source: Persephone Biosciences, Inc.

Persephone Biosciences Hits 10,000 Families on Waitlist for First-of-Its-Kind Infant Synbiotic

Persephone Biosciences Hits 10,000 Families on Waitlist for First-of-Its-Kind Infant Synbiotic
September 08, 2025 04:46 ET | Source: Research and Markets

Human Microbiome Global Forecast Report 2025 | Market Set to Surge, Reaching USD 7.09 Billion by 2031 Driven by Personalized Medicine Demand

Dublin, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The "Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral,...
September 03, 2025 13:47 ET | Source: Tiny Health

New Study: Gut Health Program Cuts Infant Eczema Odds by 83% in C-Section Babies

AUSTIN, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- A new study found that babies born by C-section had 83% lower odds of developing eczema when their families participated in a 6-month gut health...
September 02, 2025 05:41 ET | Source: Research and Markets

Microbiome Therapeutics Market Revenues to Double by 2030 - Key Opportunities Lie in Live-biotherapeutics, Personalized Medicine, and Digital Health Integrations

Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Microbiome Therapeutics Market by Products (Fecal Microbiota Transplantation, Live-Biotherapeutics, Microbiome Drugs), Therapeutic Area (Autoimmune...